HHMI
INCY icon

Howard Hughes Medical Institute’s Incyte INCY Stock Holding History

Howard Hughes Medical Institute’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-724
Closed -$91K – 77
2017
Q2 		$91K Sell
724
-486
-40% -$61.8K 0.02% 140
2017
Q1 		$162K Buy
1,210
+359
+42% +$45.7K 0.03% 124
2016
Q4 		$85K Buy
+851
New +$83K 0.02% 133

Other funds holding INCY

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Howard Hughes Medical Institute's INCY Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Incyte (INCY) in Q3 2017, closing a stake of 724 shares — an estimated $91K sold.

Howard Hughes Medical Institute first reported a position in INCY in Q4 2016 and held it in 3 quarters. The position peaked at $162K in Q1 2017. 496 funds tracked by Wall St. Rank hold INCY as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Incyte position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 724 Incyte shares in Q3 2017, an estimated $91K.
  • Howard Hughes Medical Institute first reported a position in Incyte in Q4 2016 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Incyte position peaked at $162K in Q1 2017.
  • 496 funds tracked by Wall St. Rank held Incyte as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.